{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T04:59:48Z","timestamp":1783832388691,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.yrtph.2024.105731","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T06:41:54Z","timestamp":1729665714000},"page":"105731","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Preclinical evaluation of abuse potential of the peripherally-restricted kappa opioid receptor agonist HSK21542"],"prefix":"10.1016","volume":"154","author":[{"given":"Xiaoli","family":"Gou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qidi","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyuan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JianMin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yansheng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2024.105731_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0014-2999(96)00698-X","article-title":"Effects of the \u03ba-opioid receptor agonist U-50,488 on morphine-induced place preference conditioning in the developing rat","volume":"317","author":"Bolanos","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.yrtph.2024.105731_bib2","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1007\/s00213-016-4349-z","article-title":"Nucleus accumbens hyperpolarization-activated cyclic nucleotide-gated channels modulate methamphetamine self-administration in rats","volume":"233","author":"Cao","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.yrtph.2024.105731_bib3","first-page":"5","article-title":"Molecular cloning and functional expression of a mu-opioid receptor from rat brain","volume":"44","author":"Chen","year":"1993","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.yrtph.2024.105731_bib4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neubiorev.2018.12.005","article-title":"Fentanyl: receptor pharmacology, abuse potential, and implications for treatment","volume":"106","author":"Comer","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.yrtph.2024.105731_bib5","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.conb.2004.05.005","article-title":"Mu opioid receptor: a gateway to drug addiction","volume":"14","author":"Contet","year":"2004","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.yrtph.2024.105731_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-37041-7","article-title":"Molecular mechanism of biased signaling at the kappa opioid receptor","volume":"14","author":"Daibani","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yrtph.2024.105731_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/1381612043453036","article-title":"Peripherally restricted opioid agonists as novel analgesic agents","volume":"10","author":"DeHaven-Hudkins","year":"2004","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.yrtph.2024.105731_bib8","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1007\/s00213-020-05543-7","article-title":"Modulation of cocaine-related behaviors by low doses of the potent KOR agonist nalfurafine in male C57BL6 mice","volume":"237","author":"Dunn","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.yrtph.2024.105731_bib9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.brainresbull.2023.03.012","article-title":"VU0155041, a positive allosteric modulator of mGluR4, in the nucleus accumbens facilitates extinction and inhibits the reinstatement of morphine-induced conditioned place preference in male rats","volume":"197","author":"Ebrahimi","year":"2023","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.yrtph.2024.105731_bib10","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1126\/science.1335167","article-title":"Cloning of a delta opioid receptor by functional expression","volume":"258","author":"Evans","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.yrtph.2024.105731_bib11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41586-023-06030-7","article-title":"Ligand and G-protein selectivity in the \u03ba-opioid receptor","volume":"617","author":"Han","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.yrtph.2024.105731_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-45584-4","article-title":"Effects of the novel selective \u03ba-opioid receptor agonist NP-5497-KA on morphine-induced reward-related behaviors","volume":"13","author":"Ide","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yrtph.2024.105731_bib13","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1213\/ANE.0000000000005309","article-title":"Potential for kappa-opioid receptor agonists to engineer nonaddictive analgesics: a narrative review","volume":"132","author":"Kaski","year":"2020","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.yrtph.2024.105731_bib14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1073\/pnas.89.24.12048","article-title":"The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization","volume":"89","author":"Kieffer","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yrtph.2024.105731_bib15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00001756-199410270-00043","article-title":"Pharmacological characterization of the cloned kappa opioid receptor as a kappa 1b subtype","volume":"5","author":"Lai","year":"1994","journal-title":"Neuroreport"},{"key":"10.1016\/j.yrtph.2024.105731_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00213-002-1028-z","article-title":"Effects of a newly synthesized \u03ba-opioid receptor agonist, TRK-820, on the discriminative stimulus and rewarding effects of cocaine in rats","volume":"161","author":"Mori","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.yrtph.2024.105731_bib17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jphs.2015.11.008","article-title":"Nalfurafine hydrochloride, a selective \u03ba opioid receptor agonist, has no reinforcing effect on intravenous self-administration in rhesus monkeys","volume":"130","author":"Nakao","year":"2016","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.yrtph.2024.105731_bib18","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.tips.2018.08.007","article-title":"Abuse potential of biased mu opioid receptor agonists","volume":"39","author":"Negus","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.yrtph.2024.105731_bib19","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1124\/jpet.111.186783","article-title":"Effects of peripherally restricted kappa opioid receptor agonists on pain-related stimulation and depression of behavior in rats","volume":"340","author":"Negus","year":"2012","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.yrtph.2024.105731_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0014-2999(98)00869-3","article-title":"Cloning, expression and functional role of a nociceptin\/orphanin FQ receptor in the porcine gastrointestinal tract","volume":"365","author":"Osinski","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.yrtph.2024.105731_bib21","first-page":"7","article-title":"Quantification of opioid dependence and abuse prevalence in the United States between 2017 and 2018","volume":"18","author":"Regueras","year":"2022","journal-title":"J Opioid Manag"},{"key":"10.1016\/j.yrtph.2024.105731_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28010346","article-title":"Design of \u03ba-opioid receptor agonists for the development of potential treatments of pain with reduced side effects","volume":"28","author":"Santino","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.yrtph.2024.105731_bib23","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/cts.13173","article-title":"Evaluation of the abuse potential of difelikefalin, a selective kappa\u2010opioid receptor agonist, in recreational polydrug users","volume":"15","author":"Shram","year":"2021","journal-title":"Clinical and Translational Science"},{"key":"10.1016\/j.yrtph.2024.105731_bib24","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/papr.12801","article-title":"APOLLO-2: a randomized, placebo and active-controlled phase III study investigating oliceridine (TRV130), a G protein-biased ligand at the mu-opioid receptor, for management of moderate to severe acute pain following abdominoplasty","volume":"19","author":"Singla","year":"2019","journal-title":"Pain Pract."},{"key":"10.1016\/j.yrtph.2024.105731_bib25","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1111\/cts.13538","article-title":"Assessment of the physical dependence potential of difelikefalin: randomized placebo\u2010controlled study in patients receiving hemodialysis","volume":"16","author":"Spencer","year":"2023","journal-title":"Clinical and Translational Science"},{"key":"10.1016\/j.yrtph.2024.105731_bib26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0014-2999(97)00062-9","article-title":"Differential effects of \u03bc-, \u03b4- and \u03ba-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats","volume":"324","author":"Suzuki","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.yrtph.2024.105731_bib27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0024-3205(01)00957-2","article-title":"The novel kappa-opioid receptor agonist TRK-820 suppresses the rewarding and locomotor-enhancing effects of morphine in mice","volume":"68","author":"Tsuji","year":"2001","journal-title":"Life Sci."},{"key":"10.1016\/j.yrtph.2024.105731_bib28","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0024-3205(00)00582-8","article-title":"A novel kappa-opioid receptor agonist, TRK-820, blocks the development of physical dependence on morphine in mice","volume":"66","author":"Tsuji","year":"2000","journal-title":"Life Sci."},{"key":"10.1016\/j.yrtph.2024.105731_bib29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5414\/CP201852","article-title":"One year long-term study on abuse liability of nalfurafine in hemodialysis patients","volume":"51","author":"Ueno","year":"2013","journal-title":"Int. J. Clin. Pharm. Ther."},{"key":"10.1016\/j.yrtph.2024.105731_bib30","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1124\/jpet.103.063313","volume":"310","author":"Valenzano","year":"2004","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.yrtph.2024.105731_bib31","doi-asserted-by":"crossref","first-page":"927","DOI":"10.2147\/JPR.S171013","article-title":"APOLLO-1: a randomized placebo and active-controlled phase III study investigating oliceridine (TRV130), a G protein-biased ligand at the micro-opioid receptor, for management of moderate-to-severe acute pain following bunionectomy","volume":"12","author":"Viscusi","year":"2019","journal-title":"J. Pain Res."},{"key":"10.1016\/j.yrtph.2024.105731_bib32","article-title":"Antinociceptive and antipruritic effects of HSK21542, a peripherally-restricted kappa opioid receptor agonist, in animal models of pain and itch","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.yrtph.2024.105731_bib33","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.cell.2022.12.026","article-title":"Structures of the entire human opioid receptor family","volume":"186","author":"Wang","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.yrtph.2024.105731_bib34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1073\/pnas.90.14.6736","article-title":"Cloning and functional comparison of kappa and delta opioid receptors from mouse brain","volume":"90","author":"Yasuda","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yrtph.2024.105731_bib35","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejphar.2009.01.043","article-title":"Effects of TRK-820, a selective kappa opioid receptor agonist, on rat schizophrenia models","volume":"606","author":"Yoshikawa","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.yrtph.2024.105731_bib36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s13318-023-00858-0","article-title":"Pharmacokinetics, mass balance and metabolism of [14C]HSK21542, a novel kappa opioid receptor agonist, in humans","volume":"48","author":"Yuan","year":"2023","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.yrtph.2024.105731_bib37","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/FBP.0000000000000581","article-title":"The kappa-opioid receptor agonist, nalfurafine, blocks acquisition of oxycodone self-administration and oxycodone's conditioned rewarding effects in male rats","volume":"31","author":"Zamarripa","year":"2020","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.yrtph.2024.105731_bib38","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.neuropharm.2015.09.031","article-title":"Activation of serotonin 5-HT2C receptor suppresses behavioral sensitization and naloxone-precipitated withdrawal symptoms in morphine-dependent mice","volume":"101","author":"Zhang","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.yrtph.2024.105731_bib39","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/164_2021_443","article-title":"Preclinical studies on nalfurafine (TRK-820), a clinically used KOR agonist","author":"Zhou","year":"2021","journal-title":"Handb. Exp. Pharmacol."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230024001727?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230024001727?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T03:18:31Z","timestamp":1733282311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230024001727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":39,"alternative-id":["S0273230024001727"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2024.105731","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical evaluation of abuse potential of the peripherally-restricted kappa opioid receptor agonist HSK21542","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2024.105731","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105731"}}